BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 19967146)

  • 1. Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.
    Di Minno G; Coppola A; Di Minno MN; Poon MC
    Thromb Haemost; 2009 Dec; 102(6):1157-64. PubMed ID: 19967146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glanzmann's thrombasthenia: updated.
    Nair S; Ghosh K; Kulkarni B; Shetty S; Mohanty D
    Platelets; 2002 Nov; 13(7):387-93. PubMed ID: 12487785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
    Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F
    Platelets; 2011; 22(5):321-7. PubMed ID: 21526886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal management of Glanzmann's thrombasthenia: report of 3 cases.
    Kantarci A; Cebeci I; Firatli E; Atamer T; Tuncer O
    J Periodontol; 1996 Aug; 67(8):816-20. PubMed ID: 8866321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC; Di Minno G; d'Oiron R; Zotz R
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glanzmann's thrombasthenia: a rare example of an integrin deficit].
    Perutelli P; Mori PG
    Recenti Prog Med; 1992 Oct; 83(10):577-81. PubMed ID: 1462042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa.
    Conte R; Cirillo D; Ricci F; Tassi C; Tazzari PL
    Haematologica; 1997; 82(1):73-4. PubMed ID: 9107089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum of Glanzmann's thrombasthenia.
    Badhe BA; Jayanthi S; Datta T
    Indian J Pathol Microbiol; 2000 Jul; 43(3):297-302. PubMed ID: 11218676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
    Franchini M; Lippi G
    Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb-IIIa: Is there a foetal risk?
    Léticée N; Kaplan C; Lémery D
    Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):139-42. PubMed ID: 16054952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glanzmann's thrombasthenia: an overview.
    Kannan M; Saxena R
    Clin Appl Thromb Hemost; 2009; 15(2):152-65. PubMed ID: 18930954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization.
    Bellucci S; Damaj G; Boval B; Rocha V; Devergie A; Yacoub-Agha I; Garderet L; Ribaud P; Traineau R; Socié G; Gluckman E
    Bone Marrow Transplant; 2000 Feb; 25(3):327-30. PubMed ID: 10673707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glanzmann's thrombasthenia: modulation of clinical phenotype by alpha2C807T gene polymorphism.
    D'Andrea G; Margaglione M;
    Haematologica; 2003 Dec; 88(12):1378-82. PubMed ID: 14687991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
    Kale A; Bayhan G; Yalinkaya A; Yayla M
    J Perinat Med; 2004; 32(5):456-8. PubMed ID: 15493726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
    Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures.
    d'Oiron R; Ménart C; Trzeciak MC; Nurden P; Fressinaud E; Dreyfus M; Laurian Y; Négrier C
    Thromb Haemost; 2000 May; 83(5):644-7. PubMed ID: 10823254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel homozygous mutation (c.175delG) in platelet glycoprotein ITGA2B gene as cause of Glanzmann's thrombasthenia type I.
    Vannier C; Behnisch W; Bartsch I; Sandrock K; Ertle F; Schmidt K; Busse A; Superti-Furga A; Kulozik A; Santoso S; Zieger B
    Klin Padiatr; 2010 May; 222(3):150-3. PubMed ID: 20514618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired Glanzmann's thrombasthenia caused by glycoprotein IIb/IIIa autoantibodies of the immunoglobulin G1 (IgG1), IgG2 or IgG4 subclass: a study in six cases.
    Porcelijn L; Huiskes E; Maatman R; de Kreuk A; de Haas M
    Vox Sang; 2008 Nov; 95(4):324-30. PubMed ID: 19138263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
    Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
    Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.